Chemical activators of GPN3 can engage in a variety of cellular signaling pathways to enhance the activity of this protein. Phorbol 12-myristate 13-acetate (PMA) and 1,2-Dioctanoyl-sn-glycerol (DiC8), both function as activators of protein kinase C (PKC). PKC plays a crucial role in phosphorylating target proteins, and it is plausible that GPN3, which is involved in nucleotide exchange on small GTPases, is activated through phosphorylation by PKC. Similarly, Forskolin elevates intracellular cAMP levels, subsequently activating protein kinase A (PKA), which can phosphorylate a multitude of proteins, including GPN3, to augment its activity. The increase in intracellular calcium levels triggered by Ionomycin can activate calcium-dependent protein kinases, which have the potential to phosphorylate and thereby activate GPN3.
In the realm of phosphatase inhibition, chemicals such as Okadaic acid and Calyculin A prevent the dephosphorylation of proteins by inhibiting protein phosphatases PP1 and PP2A. This activity can maintain GPN3 in a phosphorylated, active state. Anisomycin activates stress-activated protein kinases, which may phosphorylate GPN3, leading to activation. 6-Benzylaminopurine, known to activate cyclin-dependent kinases, may also target GPN3 for phosphorylation and consequent activation. Phosphatidic acid, through its activation of mTOR signaling, could contribute to the activation of GPN3 via downstream phosphorylation events within the signaling cascade. Conversely, LY294002, though primarily a PI3K inhibitor, can induce activation of kinases through feedback mechanisms, which may include those capable of phosphorylating and activating GPN3. Similarly, Rapamycin, an mTOR inhibitor, may trigger compensatory activation of other kinases that can phosphorylate GPN3. Lastly, Sphingosine-1-phosphate activates sphingosine kinase, which is part of a signaling pathway that can lead to the phosphorylation and activation of GPN3, highlighting the interconnected nature of these signaling molecules and the complex regulation of protein activity within the cell.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $40.00 $129.00 $210.00 $490.00 $929.00 | 119 | |
PMA activates protein kinase C (PKC) which is known to phosphorylate a range of target proteins. As GPN3 is involved in nucleotide exchange on small GTPases which may be regulated by phosphorylation, activation of PKC by PMA can lead to phosphorylation and activation of GPN3. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
Forskolin directly stimulates adenylyl cyclase, leading to an increase in the intracellular concentration of cAMP, which activates PKA. Activated PKA can phosphorylate various proteins, potentially including GPN3, thereby enhancing its activity. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $76.00 $265.00 | 80 | |
Ionomycin increases intracellular calcium levels, which can activate calcium-dependent protein kinases. These kinases can phosphorylate GPN3, resulting in its activation. | ||||||
1,2-Dioctanoyl-sn-glycerol | 60514-48-9 | sc-202397 sc-202397A | 10 mg 50 mg | $46.00 $249.00 | 2 | |
DiC8 is an analog of diacylglycerol (DAG) and can activate PKC. Upon PKC activation, GPN3 could be phosphorylated by PKC, leading to its functional activation. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $285.00 $520.00 $1300.00 | 78 | |
Okadaic acid is an inhibitor of protein phosphatases PP1 and PP2A. Inhibition of these phosphatases prevents dephosphorylation of proteins, potentially keeping GPN3 in a phosphorylated and active state. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A sc-24000C | 10 µg 100 µg 1 mg | $160.00 $750.00 $3000.00 | 59 | |
Similar to Okadaic acid, Calyculin A is a potent inhibitor of PP1 and PP2A, leading to sustained phosphorylation and activation of proteins including potentially GPN3. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $97.00 $254.00 | 36 | |
Anisomycin activates stress-activated protein kinases, which can lead to the phosphorylation of various substrates, possibly including GPN3, thus promoting its activation. | ||||||
6-Benzylaminopurine | 1214-39-7 | sc-202428 sc-202428A | 1 g 5 g | $20.00 $51.00 | ||
6-Benzylaminopurine is known to activate cyclin-dependent kinases. These kinases may phosphorylate GPN3, resulting in its activation. | ||||||
Phosphatidic Acid, Dipalmitoyl | 169051-60-9 | sc-201057 sc-201057B sc-201057A | 100 mg 250 mg 500 mg | $104.00 $239.00 $409.00 | ||
Phosphatidic acid can activate mTOR signaling which in turn could phosphorylate and activate downstream proteins, potentially including GPN3 through signaling cascades. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
LY294002 is a PI3K inhibitor, but as a consequence of feedback loops, it can also lead to the activation of certain kinases which might phosphorylate and activate GPN3. | ||||||